Achievements

1- The development of Egyptian Evaluation Protocols for vaccines and diagnostic antigens produced and/or imported into Egypt. CLEVB relies mainly on CFR, European Pharmacopeia and OIE (manual of diagnostic tests and vaccines for terrestrial animals) in such developments to insure that effective and safe vaccines are marketed to livestock and poultry breeders.
2- Evaluation protocols specific for evaluation of viral, bacterial & protozoal for poultry, large animals and pet vaccines, antigens and specific antisera were modified and officially issued to meet National and international requirements
3- The laboratory had an active development training programs for its staff on the techniques adopted in the field of veterinary biologics evaluation (including training in all phases of evaluation, (tests for purity, safety, potency and efficacy) stated in the standard regulations.
4- Provides support for animal health programs designed by general organization of veterinary services to protect national livestock and poultry against infectious diseases
5- Adopts high standard biotechnology methods to introduce new and more accurate methodology used in quality control of veterinary biologics.
6- Equipping all laboratories with advanced and calibrated equipment used in testing and evaluation of veterinary biologics.
7- Using molecular biology to produce different diagnostic kits.
8- The laboratory won the "State Encouragement Prize" in the field of biological science in (1999).
9- Cooperates with other research institutes and Technology and Scientific Research Academy in research projects

10-Strengthen links with national and international organizations (GOVS, FAO, OIE, PANVAC and NAMERU-3)
11- Regional technical support and training center for regional countries by providing bench training for veterinarians from Africa and Asian countries in the field of quality control of veterinary vaccines
12- CLEVB provided services for vaccine quality control and certificates upon request for different regional countries.